Tech Market Map Report — Pharmaceutical Supply Chain In Healthcare
This report looks at the supply chain companies serving pharmaceutical companies.
Pharma & Biotech
Digital Therapeutics Outlook: The Tech Transforming The Way We Treat And Manage Disease
Digital therapeutics are a growing focus within the digital health ecosystem, as funding, clinical validation, and product reimbursement gain momentum. We analyze the accelerating adoption of digital therapeutics and how they can improve patient outcomes.
ESP Vendor Assessment Matrix — Digital Pharmacy In Healthcare
This report uses the CB Insights Execution & Market Strength Positioning (ESP) Matrix to analyze vendors that deliver digital pharmacy solutions in healthcare.
Softbank-Backed Exscientia Raises $225M To Enhance Its Autonomous Drug Design Platform
Exscientia plans to advance its pipeline of AI-designed drugs into clinical testing. Here are the top line bullets you need to know.
From Vaccines To Cancer Treatments, How Pharma Partnerships Are Driving The Next Wave Of Drug Innovation
Using CB Insights’ Business Relationships data, we analyze how top pharmaceutical companies are working with startups on initiatives ranging from Covid-19 vaccines to AI-powered drug discovery.
Sequoia-Backed Benchling Raises $200M To Accelerate Cloud-Powered R&D In Life Sciences
Benchling attained unicorn status at a $4B valuation amid its IPO preparations. Here are the top-line bullets you need to know.
The Future Of Clinical Trials: How AI, Big Tech, & Covid-19 Could Make Drug Development Cheaper, Faster, & More Effective
Testing new drugs is a slow and expensive process. AI has the potential to disrupt clinical trials — from patient recruitment to adherence monitoring and data collection — and Covid-19 has catalyzed its adoption.
What Are mRNA Therapies, And How Are They Used For Vaccines?
As clinical trials ramp up, we dig into how mRNA therapies help the body combat infections, genetic diseases, and even cancer.
State Of Healthcare Report: Investment & Sector Trends To Watch
Our healthcare report provides a data-driven look at global healthcare technology investment trends, top deals, active investors, and corporate activity.
Cold Chain Captures Executive Attention In Q4’20
The temperature requirements for Covid-19 vaccines have focused attention on the cold chain, with nearly 6x more earnings calls mentions vs. last year. Here are the top-line bullets you need to know.
Real World Evidence For Healthcare Is Gaining Momentum
Covid-19 has accelerated the adoption of real world evidence across healthcare, driving a record level of news mentions in Q3'20. Here are the top-line bullets you need to know.
Where Pharma Giants Are Betting On Artificial Intelligence In Healthcare
Pharma incumbents like Merck and Roche are investing in healthcare AI startups to enable precision diagnostics, scour medical literature for clinical support, predict optimal drug structures, and more.
What Is Cold Chain?
For temperature-sensitive products from food to vaccines, cold chain technology enables temperature control and monitoring throughout the supply chain.
Unbundling LabCorp: How Traditional Lab Testing Is Being Disrupted
From basic testing to clinical trials, here’s how LabCorp is being unbundled.
Here’s How Big Pharma Is Partnering To Transform Clinical Trials
Reeling from Covid-19’s widespread disruption, healthcare players are turning to partnerships to strengthen their clinical trial capabilities. We use CB Insights Business Relationships data to analyze what this signals about the future of clinical trials.
How Quantum Tech Could Change Drug Discovery, Diagnostics, And Patient Privacy
Advances in harnessing quantum phenomena could shake up healthcare. We look at the applications — and possible risks — to watch as the space matures.
Healthcare AI Trends To Watch
AI in healthcare has gained significant traction during the pandemic, from combing scientific papers on coronaviruses to searching CT scans for Covid-19 symptoms. We look at where AI will have a lasting impact on the industry.
State Of Healthcare Q3’20 Report: Sector And Investment Trends To Watch
Our healthcare report provides a data-driven look at global healthcare technology investment trends, top deals, active investors, and corporate activity.
How Researchers Are Leveraging New Technologies To Design Better — And Faster — Clinical Trials
With Covid-19 throwing clinical trial speed into the spotlight, we dive into the new innovations — like "organ-on-a-chip" tech and digital twins — enabling researchers to design better-informed, more efficient studies.
Women’s Health Trends To Watch In 2020
From novel genomic datasets to smartphone fertility tracking, advances in women's health continue to gain momentum. Our analysts identified 9 of the biggest women’s health trends to watch in 2020.
What We Can Learn From Healthcare Smart Money VCs’ Bets In Telehealth, AI, Gene Therapy, & More
The CB Insights Healthcare Smart Money list features the world's top-performing VCs for healthcare investment. We analyze their portfolios to identify where they see opportunity and risk.
The FDA Relaxed Regulation On Digital Therapeutics For Psychiatric Disorders — Here’s What It Means For The Industry
News Analysis
New FDA guidance means that digital therapeutics could get to at-risk patients faster amid the Covid-19 pandemic, and healthcare stakeholders are already reacting.
How Covid-19 Is Pushing Healthcare Stakeholders, Governments, And Tech Giants To Innovate
The pandemic has driven governments, industry players, and tech incumbents to adapt and innovate healthcare initiatives in the face of surging demand.
These Technologies Could Enable Faster, More Effective Clinical Trials
Clinical trials may become more efficient as emerging tech transforms processes like study management, patient recruitment, and more. We look at how the clinical trial landscape is changing.
Companies Are Partnering To Address The Threat Of New Pathogens
Across industries, companies are forging partnerships aimed at diagnosing and treating Covid-19. We highlight some of these initiatives and what this trend could mean for future emerging pathogens.
How Tech Is Streamlining The Development Of Complex Gene & Cell Therapies
The rise of cell and gene therapies comes with unique supply chain challenges, from manufacturing to distribution. We look at some of the tech solutions that could help smooth the complex development process.